NEUROTOXICITY SYNDROMES

Clinical trials for NEUROTOXICITY SYNDROMES explained in plain language.

Never miss a new study

Get alerted when new NEUROTOXICITY SYNDROMES trials appear

Sign up with your email to follow new studies for NEUROTOXICITY SYNDROMES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Can a common arthritis drug tame CAR-T's dangerous side effects?

Symptom relief Completed

This phase 2 trial tested whether adding the drug anakinra (Kineret) to standard CAR-T cell therapy could prevent nerve toxicity in 15 people with relapsed or refractory non-Hodgkin lymphoma. Participants received anakinra injections for a week alongside their CAR-T infusion. The…

Matched conditions: NEUROTOXICITY SYNDROMES

Phase: PHASE2 • Sponsor: Marcela V. Maus, M.D.,Ph.D. • Aim: Symptom relief

Last updated Jun 27, 2026 07:59 UTC

NEUROTOXICITY SYNDROMES

Get alerted when new NEUROTOXICITY SYNDROMES trials appear

Can a common arthritis drug tame CAR-T's dangerous side effects?